February 17, 2023 Apellis Pharmaceuticals, Inc. (Waltham, MA) today announced that the U.S. FDA has approved SYFOVRE™ (pegcetacoplan...

January 28, 2022 Genentech, a member of the Roche Group, today announced that the FDA has approved Vabysmo™ (faricimab-svoa) for the...

September 1, 2019 Anti-VEGF therapy for exudative macular degeneration places a significant treatment burden both upon patients who must...

November 11, 2017 The MUST trial compared the effectiveness of systemic therapy vs. fluocinolone acetonide implant for severe uveitis. ...